Scalper1 News
This past year brought some sea-changing drugs … as well as a few that didn’t quite work out as planned. Herewith, a highly subjective ranking of the most newsworthy drug launches of 2013: 1. Sovaldi: No drug approved this year had quite the expectations of Gilead Sciences’ (GILD) hepatitis C drug, which the FDA approved on Dec. 6. Although it’s still in the very early days for a drug launch — analysts aren’t expecting annual sales to hit Scalper1 News
Scalper1 News